Illumina has announced an expanded partnership with Integrated DNA Technologies (IDT) to develop solutions for next-generation sequencing (NGS) library preparation multiplexing and a co-marketing agreement that links Illumina library prep with the IDT Exome Enrichment
SolveBio and Elsevier have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways
The global Computer Aided Engineering (CAE) market is anticipated to reach $12.8 billion by 2025, according to a new report by Grand View Research, a US-based market research and consulting company
Market research firm Technavio has prepared a report forecasting the global LIMS market growth from the period of 2017-2021. In the report Technavio’s analysts forecast the global LIMS market to grow at a CAGR of 8.94 per cent during the period 2017-2021
Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s StarDrop software
Autoscribe Informatics has announced that it has strengthened its technical marketing and support team on both sides of the Atlantic.
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences research and development, is calling upon the industry to improve collaborative efforts to use patient data to its full effect.
Intel has joined the race to develop driverless cars this week as the company has announced the acquisition of Mobileye for £15 billion
Thermo Fisher Scientific has announced that it has acquired informatics software provider Core Informatics - a company that specialises cloud-based software to support scientific data management
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences research and development, has appointed an advisory board to guide its strategy.
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
